- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01966926
Self-Weighing Instruction Feasibility Study
30 oktober 2019 bijgewerkt door: University of Minnesota
Scant data have been reported on the effects of weight self-monitoring during weight control.
The purpose of this pilot project was to consider the questions: Is it possible to assign participants to engage in daily weight self-monitoring, and are there differential effects on mood of daily versus weekly weighing?
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This study tested the feasibility of assigning participants to daily or weekly weighing, monitored adherence to weighing instructions, and tracked additional behavioral and psychosocial indicators over a period of six months.
It was hypothesized that there would be no differences in mood or adherence between daily versus weekly weighing conditions.
Knowledge about the benefits of frequent self-weighing may shape public health recommendations for regular weighing as a weight reduction or obesity prevention strategy.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
30
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Minnesota
-
Minneapolis, Minnesota, Verenigde Staten, 55454
- University of Minnesota
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar tot 64 jaar (Volwassen)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Body mass index between 25 and 35 kg/m2
Exclusion Criteria:
- Current weight loss program participation
- Chronic health conditions (diabetes, cancer, heart disease, psychiatric disorders requiring medication)
- Current or past eating disorder
- Current pregnancy or pregnant in past year
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Daily Weight Tracking
weighing frequency instructions and tips
|
Weekly emails with nutrition, physical activity, and weight tracking tips sent for 24 weeks
|
|
Experimenteel: Weekly Weight Tracking
weighing frequency instructions and tips
|
Weekly emails with nutrition, physical activity, and weight tracking tips sent for 24 weeks
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Adherence to Weight Tracking Instructions
Tijdsspanne: 6 months
|
Participants were assigned to daily or weekly weight tracking, and were asked to return postcards once a week with weights recorded (7 for daily, 1 for weekly).
|
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in Depression Ratings
Tijdsspanne: baseline to 6 months
|
Ratings of depressed mood, assessed by the Beck Depression Inventory, were obtained at baseline, three, and six months; the comparison of depression scores between groups and over time from baseline to 3 and 6 months was considered as a secondary outcome and analyzed using repeated measures multivariate analysis of variance (MANOVA).
Scores on the inventory range from 0 to 63, with higher scores indicating greater presence of depressive symptoms.
Scores from 0-10 represent normal mood; 11-16 = mild mood disturbance; 17-20 = borderline clinical depression; 21-30 = moderate depression; 31-40 = severe depression; > 40 = extreme depression.
|
baseline to 6 months
|
|
Changes in Anxiety
Tijdsspanne: baseline to 6 months
|
Ratings of anxiety, assessed by the Beck Anxiety Inventory, were assessed at baseline, three, and six months; a comparison of anxiety scores between groups and over time from baseline to 3 and 6 months was considered a secondary outcome and analyzed using repeated measures MANOVA.
Possible scores on the scale range from 0-63.
Scores from 0-7 indicate minimal anxiety; 8-15 = mild anxiety; 16-25 = moderate anxiety; 26-63 = severe anxiety.
|
baseline to 6 months
|
|
Changes in Body Image
Tijdsspanne: baseline to 6 months
|
Changes in self-reported body image were assessed at baseline, three, and six months using the Appearance subscale of the Multidimensional Body Image Questionnaire.
The subscale has a range of 0 to 42, with higher scores indicating better body image.
A comparison of body image scores between groups and over time from baseline to 3 and 6 months was considered a secondary outcome and analyzed using repeated measures MANOVA.
|
baseline to 6 months
|
|
Changes in Barriers to Weight Tracking
Tijdsspanne: baseline to 6 months
|
Perceived barriers to self-weighing were assessed at baseline, three, and six months using a scale created for this study.
The scale has a range of 18 to 90, with higher scores indicating greater perceptions of barriers to self-weighing.
A comparison of barriers scores between groups and over time from baseline to 3 and 6 months was considered a secondary outcome and analyzed using repeated measures MANOVA.
|
baseline to 6 months
|
|
Changes in Perceptions of Weight Tracking
Tijdsspanne: three to six months
|
Perceptions of weight tracking (ease of remembering and understanding, usefulness, awareness, interest, reward value, satisfaction, motivational value) were assessed at three and six months using a scale created for the study.
The scale has a range of 0 to 64, with higher scores indicating greater perceptions of favorability of weight tracking.
A comparison of perceptions scores between groups and over time from 3 and 6 months was considered a secondary outcome and analyzed using repeated measures MANOVA.
|
three to six months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Jennifer A Linde, Ph.D., University of Minnesota
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 oktober 2009
Primaire voltooiing (Werkelijk)
1 mei 2010
Studie voltooiing (Werkelijk)
1 mei 2010
Studieregistratiedata
Eerst ingediend
16 oktober 2013
Eerst ingediend dat voldeed aan de QC-criteria
17 oktober 2013
Eerst geplaatst (Schatting)
22 oktober 2013
Updates van studierecords
Laatste update geplaatst (Werkelijk)
1 november 2019
Laatste update ingediend die voldeed aan QC-criteria
30 oktober 2019
Laatst geverifieerd
1 oktober 2019
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 0807S41483
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .